| 000 | 00884 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513045629.0 | ||
| 264 | 0 | _c19950310 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(95)90397-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFitzgerald, J M | |
| 245 | 0 | 0 |
_aThe downside of isoniazid chemoprophylaxis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 1995 |
||
| 300 |
_a404 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xprevention & control |
| 773 | 0 |
_tLancet (London, England) _gvol. 345 _gno. 8947 _gp. 404 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(95)90397-6 _zAvailable from publisher's website |
| 999 |
_c7853283 _d7853283 |
||